Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy

por Schmidt, MK, van Sprundel, TC, Rookus, MA, Brohet, R, van Asperen, CJ, Rutgers, EJTh, Tollenaar, RAEM, van 't Veer, LJ
Publicado 2005

Genetic determinants of breast cancer characteristics and outcome in women under 50 years of age

por Schmidt, MK, van der Plas, A, de Kemp, SR, Klaver, S, Nota, B, Maertzdorf, B, de Groot, R, Udo, R, Smit, VTHBM, Broeks, A, Peterse, JL, van Leeuwen, FE, Tollenaar, RAEM, van 't Veer, LJ
Publicado 2005

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer

por van Pelt, G.W., Krol, J.A., Lips, I.M., Peters, F.P., van Klaveren, D., Boonstra, J.J., de Steur, W.O., Tollenaar, R.A.E.M., Farina Sarasqueta, A., Mesker, W.E., Slingerland, M.
Publicado 2019